Press Releases

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

ProPharma Recognized as a Top Outsourcing Partner

ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.

Huateng Pharma to Exhibit at CPHI China 2024

MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer

Leading Pediatric Osteosarcoma Nonprofit to Present $350,000 to 5 Scientists on June 21 to Find Kinder Treatments for Patients

Onyx Scientific Aims for European Growth with New BD Hire

Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.

CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program

Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials

Syngene launches platform for rapid, enhanced protein production

Ardena appoints Jeremie Trochu as Chief Executive Officer

Ardena has appointed Jeremie Trochu as Chief Executive Officer following the retirement of Harry Christiaens, who will remain on the company's board after 20 years of leadership. Trochu, previously with Catalent, Inc., brings extensive experience in the life sciences and CDMO industry, positioning Ardena for continued growth and international expansion.

AES Clean Technology Announces Appointment of New CEO

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024

PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries.

Datacubed Health Sharpens Focus on eCOA and ePRO With New CEO

Datacubed Health announced the appointment of Kyle Hogan as its new chief executive officer (CEO).

Creative Enzymes Introduces Leaf-branch Compost Poly (ethylene terephthalate) Hydrolase for Sustainable PET Degradation

Creative Enzymes Introduces Recombinant Porcine Citrate Synthase with Enhanced C-His Tag for Accelerated Metabolic Research

ABOH Announces Winner of $150,000 Lung Cancer Research Award

We are announcing our 2024 recipient of the Julie Swedberg YOLO Cancer Research Award of $150,000. This is a new research award named in honor of Julie Swedberg, who died from lung cancer in 2023 as a 48-year-old non-smoker. Jessica Konen, PhD, of Emory University Winship Cancer Institute, will receive this national award in recognition and support of her work entitled MiR-29 as a master regulator of anti-tumor immunity. The project focuses on defining a novel mechanism of resistance to immune checkpoint inhibitor treatments in lung cancer.

Unraveling the Mysteries of Protein Lipidation with Creative Proteomics